文献速递产科母胎医学

足月出生且产前暴露于糖皮质激素儿童的长期结局

Long-term childhood outcomes for babies born at term who were exposed to antenatal corticosteroids.
PubMed 文献 · Am J Obstet Gynecol · 2022-07-21

这项回顾性队列研究纳入3556名≥5岁的足月出生儿童,比较产前因先兆早产接受糖皮质激素(均为倍他米松)暴露者与未暴露者的长期结局。暴露组哮喘、注意力缺陷及发育迟缓诊断率与对照组无显著差异,但体重百分位<10%的比值比升高(OR 2.00,95%CI 1.22-3.25)。

要点

  • 足月产前糖皮质激素暴露儿童哮喘诊断率12.6% vs 11.6%,无显著差异。
  • 暴露组体重百分位<10%的比值比为2.00(95%CI 1.22-3.25)。
  • 注意力缺陷与发育迟缓诊断率在两组间无显著差异。

核心结论

  • 足月出生且产前暴露于糖皮质激素的儿童,其体重百分位低于10%的比值可能升高;但哮喘、发育迟缓及注意力缺陷障碍的诊断率无差异。

研究设计与样本

  • 回顾性队列研究,纳入3556名≥5岁、胎龄≥37周出生、母亲孕期诊断为先兆早产的儿童。
  • 暴露组629名(17.6%)接受产前糖皮质激素(均为倍他米松),对照组2927名(82.3%)母亲因先兆早产接受评估但未接受糖皮质激素注射。

主要发现

  • 暴露组母亲合并症(糖尿病、高血压)发生率更高(P≤.01)。
  • 哮喘诊断率暴露组12.6% vs 对照组11.6%,注意力缺陷障碍与发育迟缓的P值分别为.47、.54和.10。
  • 控制母婴特征后,哮喘的OR为1.05(95%CI 0.79-1.39)。
  • 足月出生暴露组儿童体重百分位<10%的OR为2.00(95%CI 1.22-3.25)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antenatal corticosteroids improve neonatal outcomes when administered to infants who are at risk of preterm delivery. Many women who receive antenatal corticosteroids for threatened preterm labor proceed to deliver at term. Thus, long-term outcomes should be evaluated for term-born infants who were exposed to antenatal corticosteroids in utero. OBJECTIVE: This study aimed to compare long-term outcomes between term-born children aged ≥5 years who were born to women who received antenatal corticosteroids for threatened preterm labor and children whose mothers were also evaluated for threatened preterm labor but did not receive antenatal corticosteroids. STUDY DESIGN: We performed a retrospective cohort study of children born at ≥37 weeks' gestation, aged ≥5 years, and born to mothers diagnosed with threatened preterm labor during pregnancy. The primary exposure of interest was receiving antenatal corticosteroids. Among the collected childhood medical conditions, the primary outcome of interest was a diagnosis of asthma. RESULTS: Of the 3556 term-born children aged ≥5 years, 629 (17.6%) were exposed to antenatal corticosteroids (all betamethasone), and 2927 (82.3%) were controls whose mothers were evaluated for threatened preterm birth but did not get antenatal corticosteroid injections. Women receiving antenatal corticosteroids had higher rates of maternal comorbidities (diabetes mellitus, hypertension; P≤.01). Antenatal corticosteroid-exposed children had no difference in diagnosis of asthma (12.6% vs 11.6%), attention deficit disorder, or developmental delay (P=.47, .54, and .10, respectively). Controlling for maternal and neonatal characteristics, asthma was not different between those exposed to antenatal corticosteroids and controls (odds ratio, 1.05; 95% confidence interval, 0.79-1.39). The odds of the child's weight percentile being <10% were increased for antenatal corticosteroid-exposed children born at term (odds ratio, 2.00; 95% confidence interval, 1.22-3.25). CONCLUSION: Children born at term who were exposed to antenatal corticosteroids may have increased odds of being in a lower growth percentile than those not exposed. However, rates of diagnoses such as asthma, developmental delay, and attention deficit disorders were not different.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Osteen SJ, Yang Z, McKinzie AH, et al. Long-term childhood outcomes for babies born at term who were exposed to antenatal corticosteroids. Am J Obstet Gynecol. 2022. PMID: 35872037. doi:10.1016/j.ajog.2022.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。